Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea
Part of paid clinical trials in North Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07332442
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Obstructive Sleep Apnea
- Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Eszopiclone — DRUG3mg for \< 65 and 2mg for ≥ 65 years
- Placebo — DRUGMatched placebo
Study Details
The study design is a randomized, controlled clinical trial to test the hypothesis that arousal threshold (ArTH) will affect how individuals with obstructive sleep apnea (OSA, Apnea-Hypopnea Index (AHI) of 10/hour of higher) respond to CPAP therapy regarding adherence and cognitive function (executive function). Investigators hypothesize that raising ArTH with eszopiclone will improve adherence to CPAP and neurocognitive function with CPAP therapy. Investigators also hypothesize that a lower baseline ArTH is associated with worse CPAP adherence, while a higher baseline ArTH is associated with improved neurocognitive outcomes with CPAP therapy.
Key Dates
- Start date
- May 18, 2026
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2030
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: EszopicloneParticipants will receive eszopiclone the night of the laboratory split-night polysomnography (PSG, sleep monitoring with and without CPAP therapy). Following polysomnography, participants continue with eszopiclone and CPAP therapy
- Placebo Comparator: PlaceboParticipants will receive placebo the night of the laboratory split-night polysomnography (PSG, sleep monitoring with and without CPAP therapy). Following polysomnography, participants continue with placebo and CPAP therapy
Primary Outcome Measure
CPAP adherence [ Time Frame: Daily over 3 months ]
Central Contacts
- Andrey Zinchuk, MD, MHS475-655-6199
- Iouri Kreinin, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale Centers for Sleep Medicine | North Haven | Connecticut | 06347 | - |
Find similar trials in North Haven, CT
Related Studies
- The Recovery in Stroke Using PAP StudyRecruiting · Yale University · New Haven, Connecticut
- Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA StudyPHASE4 · Recruiting · Yale University · New Haven, Connecticut
- OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?Recruiting · Connecticut Children's Medical Center · Hartford, Connecticut
- Computer Models of Airways in Children and Young Adults With Sleep Apnea and Down SyndromeEnrolling By Invitation · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio